<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05022992</url>
  </required_header>
  <id_info>
    <org_study_id>2020-03179</org_study_id>
    <nct_id>NCT05022992</nct_id>
  </id_info>
  <brief_title>Effects of a Single Bout of Resistance Training Session on Hormonal Response in Pre-pubertal and Pubertal Boys</brief_title>
  <official_title>Effects of a Single Bout of Resistance Training Session on Hormonal Response in Pre-pubertal and Pubertal Boys</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Umeå University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Umeå University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      : Resistance training induces strength gains in both children and adolescents. Exercise&#xD;
      training is linked to anabolic functions through the GH-IGF-I axis. This has been&#xD;
      demonstrated in studies showing a higher activity of GH and IGF-I in fitter adolescents and&#xD;
      adults. Exercise also stimulates pro-inflammatory cytokines (IL-1β, IL-6, TNF-α) that&#xD;
      suppress the GH-IGF-I axis. This has been observed in endurance-type training, while&#xD;
      resistance training has received less attention.&#xD;
&#xD;
      Boys experience a significant physiological muscle-growth change during puberty that is&#xD;
      associated with increases in boys androgen levels. How maturation affects the hormonal&#xD;
      response to resistance training in boys is unclear. Therefore, the purpose of the study is to&#xD;
      compare the acute effects of a single bout of resistance training on hormones and&#xD;
      pro-inflammatory cytokines in pre-pubertal and pubertal boys.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Preliminary measurements:&#xD;
&#xD;
      Preliminary testing will include anthropometric measurements of body mass, height, body fat&#xD;
      percentage, and lean leg volume (LLV). The maturation stage will be determined according to&#xD;
      the Tanner scale. There will also be an assessment of maximal strength testing to determine&#xD;
      exercise intensity for each individual. Two familiarization sessions will be conducted for&#xD;
      muscular strength before the muscular strength testing session.&#xD;
&#xD;
      Main trial A venous blood sample will be collected pre-exercise at resting condition. The&#xD;
      trial will start with a standardized warm-up followed by a short (20-30 min), high-intensity&#xD;
      whole-body resistance training session. Venous blood samples will be collected immediately&#xD;
      after the completion of the training session and during the recovery period.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">September 2021</start_date>
  <completion_date type="Anticipated">March 2022</completion_date>
  <primary_completion_date type="Anticipated">December 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Growth Hormone Baseline</measure>
    <time_frame>Baseline testing before the exercise intervention (Pre values)</time_frame>
    <description>Blood Concentration of Growth Hormone</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from Baseline Growth Hormone Post exercise</measure>
    <time_frame>Right after the completion of the exercise intervention (Post values)</time_frame>
    <description>Blood Concentration of Growth Hormone</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from Baseline Growth Hormone 15 minutes post exercise</measure>
    <time_frame>15 minutes after the completion of the exercise intervention (Post-15 values)</time_frame>
    <description>Blood Concentration of Growth Hormone</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from Baseline Growth Hormone 30 minutes post exercise</measure>
    <time_frame>30 minutes after the completion of the exercise intervention (Post-30 values)</time_frame>
    <description>Blood Concentration of Growth Hormone</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Insulin-like Growth Factor-1 Baseline</measure>
    <time_frame>Baseline testing before the exercise intervention (Pre values)</time_frame>
    <description>Blood concentration of Insulin-like Growth Factor-1</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from Baseline Insulin-like Growth Factor-1 Post exercise</measure>
    <time_frame>Right after the completion of the exercise intervention (Post values)</time_frame>
    <description>Blood concentration of Insulin-like Growth Factor-1</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from Baseline Insulin-like Growth Factor-1 15 minutes Post exercise</measure>
    <time_frame>15 minutes after the completion of the exercise intervention (Post-15 values)</time_frame>
    <description>Blood concentration of Insulin-like Growth Factor-1</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from Baseline Insulin-like Growth Factor-1 30 minutes Post exercise</measure>
    <time_frame>30 minutes after the completion of the exercise intervention (Post-30 values)</time_frame>
    <description>Blood concentration of Insulin-like Growth Factor-1</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Cortisol Baseline</measure>
    <time_frame>Baseline testing before the exercise intervention (Pre values)</time_frame>
    <description>Blood concentration of Cortisol</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from Baseline Cortisol Post exercise</measure>
    <time_frame>Right after the completion of the exercise intervention (Post values)</time_frame>
    <description>Blood concentration of Cortisol</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from Baseline Cortisol 15 minutes Post exercise</measure>
    <time_frame>15 minutes after the completion of the exercise intervention (Post-15 values)</time_frame>
    <description>Blood concentration of Cortisol</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from Baseline Cortisol 30 minutes Post exercise</measure>
    <time_frame>30 minutes after the completion of the exercise intervention (Post-30 values)</time_frame>
    <description>Blood concentration of Cortisol</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Testosterone Baseline</measure>
    <time_frame>Baseline testing before the exercise intervention (Pre values)</time_frame>
    <description>Blood concentration of testosterone</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from Baseline Testosterone Post Exercise</measure>
    <time_frame>Right after the completion of the exercise intervention (Post values)</time_frame>
    <description>Blood concentration of testosterone</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from Baseline Testosterone 15 minutes Post Exercise</measure>
    <time_frame>15 minutes after the completion of the exercise intervention (Post-15 values)</time_frame>
    <description>Blood concentration of testosterone</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from Baseline Testosterone 30 minutes Post Exercise</measure>
    <time_frame>30 minutes after the completion of the exercise intervention (Post-30 values)</time_frame>
    <description>Blood concentration of testosterone</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Interleukin-6 Baseline</measure>
    <time_frame>Baseline testing before the exercise intervention (Pre values)</time_frame>
    <description>Blood concentration of Interleukin-6</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from Baseline Interleukin-6 Post Exercise</measure>
    <time_frame>Right after the completion of the exercise intervention (Post values)</time_frame>
    <description>Blood concentration of Interleukin-6</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from Baseline Interleukin-6 15 minutes Post Exercise</measure>
    <time_frame>15 minutes after the completion of the exercise intervention (Post-15 values)</time_frame>
    <description>Blood concentration of Interleukin-6</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from Baseline Interleukin-6 30 minutes Post Exercise</measure>
    <time_frame>30 minutes after the completion of the exercise intervention (Post-30 values)</time_frame>
    <description>Blood concentration of Interleukin-6</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Interleukin-1 alpha Baseline</measure>
    <time_frame>Baseline testing before the exercise intervention (Pre values)</time_frame>
    <description>Blood concentration of Interleukin-1 alpha</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from Baseline Interleukin-1 alpha Post Exercise</measure>
    <time_frame>Right after the completion of the exercise intervention (Post values)</time_frame>
    <description>Blood concentration of Interleukin-1 alpha</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from Baseline Interleukin-1 alpha 15 minutes Post Exercise</measure>
    <time_frame>15 minutes after the completion of the exercise intervention (Post-15 values)</time_frame>
    <description>Blood concentration of Interleukin-1 alpha</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from Baseline Interleukin-1 alpha 30 minutes Post Exercise</measure>
    <time_frame>30 minutes after the completion of the exercise intervention (Post-30 values)</time_frame>
    <description>Blood concentration of Interleukin-1 alpha</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Tumor Necrosis Factor alpha Baseline</measure>
    <time_frame>Baseline testing before the exercise intervention (Pre values)</time_frame>
    <description>Blood concentration of Tumor Necrosis Factor alpha</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from Baseline Tumor Necrosis Factor alpha Post Exercise</measure>
    <time_frame>Right after the completion of the exercise intervention (Post values)</time_frame>
    <description>Blood concentration of Tumor Necrosis Factor alpha</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from Baseline Tumor Necrosis Factor alpha 15 minutes Post Exercise</measure>
    <time_frame>15 minutes after the completion of the exercise intervention (Post-15 values)</time_frame>
    <description>Blood concentration of Tumor Necrosis Factor alpha</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from Baseline Tumor Necrosis Factor alpha 30 minutes Post Exercise</measure>
    <time_frame>30 minutes after the completion of the exercise intervention (Post-30 values)</time_frame>
    <description>Blood concentration of Tumor Necrosis Factor alpha</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sex Hormone Binding Globulin Baseline</measure>
    <time_frame>Baseline testing before the exercise intervention (Pre values)</time_frame>
    <description>Blood concentration of Sex Hormone Binding Globulin</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from Baseline Baseline Sex Hormone Binding Post Exercise</measure>
    <time_frame>Right after the completion of the exercise intervention (Post values)</time_frame>
    <description>Blood concentration of Sex Hormone Binding Globulin</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from Baseline Baseline Sex Hormone Binding 15 minutes Post Exercise</measure>
    <time_frame>15 minutes after the completion of the exercise intervention (Post-15 values)</time_frame>
    <description>Blood concentration of Sex Hormone Binding Globulin</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from Baseline Sex Hormone Binding Globulin 30 minutes Post Exercise</measure>
    <time_frame>30 minutes after the completion of the exercise intervention (Post-30 values)</time_frame>
    <description>Blood concentration of Sex Hormone Binding Globulin</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Hormones</condition>
  <condition>Cytokines</condition>
  <arm_group>
    <arm_group_label>Resistance Training Session</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Resistance training. Heavy resistance training. 10 reps x 3 set of upper- and lower-body resistance exercises</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Control activity. None-exercising. 30 min of rest</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Resistance Training</intervention_name>
    <description>Both groups will perform a resistance training session consisted of 10 reps x 3 set of upper- and lower-body resistance exercises.</description>
    <arm_group_label>Resistance Training Session</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Healthy boys (n=40)&#xD;
&#xD;
          -  Physically active, defined as a minimum of 2 years experience in a sports club&#xD;
&#xD;
          -  Biological age range: 20 pre-pubertal (Tanner I-II) - 20 pubertal (Tanner III-IV) boys&#xD;
&#xD;
          -  No previous experience of structured resistance training&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Chronic diseases that affect full participation&#xD;
&#xD;
          -  Injuries that limit full participation&#xD;
      </textblock>
    </criteria>
    <gender>Male</gender>
    <gender_based>Yes</gender_based>
    <minimum_age>9 Years</minimum_age>
    <maximum_age>17 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Apostolos Theos, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Umeå University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Apostolos Theos, PhD</last_name>
    <phone>+46702811565</phone>
    <email>apostolos.theos@umu.se</email>
  </overall_contact>
  <location>
    <facility>
      <name>Umeå Movement and Exercise Laboratory, Umeå University</name>
      <address>
        <city>Umeå</city>
        <state>Västerbotten</state>
        <zip>901 87</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <contact>
      <last_name>Apostolos Theos, PhD</last_name>
      <phone>+46702811565</phone>
      <email>apostolos.theos@umu.se</email>
    </contact>
    <contact_backup>
      <last_name>Tobias Stenlund, PhD</last_name>
      <phone>+46907868040</phone>
      <email>tobias.stenlund@umu.se</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>June 11, 2021</study_first_submitted>
  <study_first_submitted_qc>August 20, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">August 26, 2021</study_first_posted>
  <last_update_submitted>August 20, 2021</last_update_submitted>
  <last_update_submitted_qc>August 20, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 26, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Umeå University</investigator_affiliation>
    <investigator_full_name>Apostolos Theos</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

